These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25512082)

  • 1. Claudin-1 polymorphism modifies the effect of mold exposure on the development of atopic dermatitis and production of IgE.
    Yu HS; Kang MJ; Kwon JW; Lee SY; Lee E; Yang SI; Jung YH; Hong K; Kim YJ; Lee SH; Kim HJ; Kim HY; Seo JH; Kim BJ; Kim HB; Hong SJ
    J Allergy Clin Immunol; 2015 Mar; 135(3):827-30.e5. PubMed ID: 25512082
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral treatment with Aloe polysaccharide ameliorates ovalbumin-induced atopic dermatitis by restoring tight junctions in skin.
    Na K; Lkhagva-Yondon E; Kim M; Lim YR; Shin E; Lee CK; Jeon MS
    Scand J Immunol; 2020 Mar; 91(3):e12856. PubMed ID: 31794090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-33 impacts on the skin barrier by downregulating the expression of filaggrin.
    Seltmann J; Roesner LM; von Hesler FW; Wittmann M; Werfel T
    J Allergy Clin Immunol; 2015 Jun; 135(6):1659-61.e4. PubMed ID: 25863977
    [No Abstract]   [Full Text] [Related]  

  • 4. Mold elicits atopic dermatitis by reactive oxygen species: Epidemiology and mechanism studies.
    Kim HJ; Lee E; Lee SH; Kang MJ; Hong SJ
    Clin Immunol; 2015 Dec; 161(2):384-90. PubMed ID: 26205459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights in the pathogenesis of atopic dermatitis.
    Ong PY
    Pediatr Res; 2014 Jan; 75(1-2):171-5. PubMed ID: 24192701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claudin-1 decrease impacts epidermal barrier function in atopic dermatitis lesions dose-dependently.
    Bergmann S; von Buenau B; Vidal-Y-Sy S; Haftek M; Wladykowski E; Houdek P; Lezius S; Duplan H; Bäsler K; Dähnhardt-Pfeiffer S; Gorzelanny C; Schneider SW; Rodriguez E; Stölzl D; Weidinger S; Brandner JM
    Sci Rep; 2020 Feb; 10(1):2024. PubMed ID: 32029783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mold exposure affects the development of atopic dermatitis in infants with skin barrier dysfunction.
    Lee E; Lee SY; Yoon JS; Jung S; Hong SJ
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):372-374.e1. PubMed ID: 30220297
    [No Abstract]   [Full Text] [Related]  

  • 8. Bortezomib, a proteasome inhibitor, alleviates atopic dermatitis by increasing claudin 1 protein expression.
    Kim YE; Cho N; Cheon S; Kim KK
    Biochem Biophys Res Commun; 2017 Nov; 493(1):744-750. PubMed ID: 28859979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions.
    Wang X; Jiang X; Yu X; Liu H; Tao Y; Jiang G; Hong M
    J Cell Mol Med; 2017 Nov; 21(11):2926-2936. PubMed ID: 28597545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tight junction defects in patients with atopic dermatitis.
    De Benedetto A; Rafaels NM; McGirt LY; Ivanov AI; Georas SN; Cheadle C; Berger AE; Zhang K; Vidyasagar S; Yoshida T; Boguniewicz M; Hata T; Schneider LC; Hanifin JM; Gallo RL; Novak N; Weidinger S; Beaty TH; Leung DY; Barnes KC; Beck LA
    J Allergy Clin Immunol; 2011 Mar; 127(3):773-86.e1-7. PubMed ID: 21163515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous skin biome and keratinocyte genomic capture reveals microbiome differences by depth of sampling.
    Stevens ML; Gonzalez T; Schauberger E; Baatyrbek Kyzy A; Andersen H; Spagna D; Kalra MK; Martin LJ; Haslam D; Herr AB; Biagini Myers JM; Khurana Hershey GK
    J Allergy Clin Immunol; 2020 Dec; 146(6):1442-1445. PubMed ID: 32320735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Lactobacillus acidophilus strain L-55 on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
    Sunada Y; Nakamura S; Kamei C
    Int Immunopharmacol; 2008 Dec; 8(13-14):1761-6. PubMed ID: 18790088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
    Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
    Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis.
    Rebane A; Zimmermann M; Aab A; Baurecht H; Koreck A; Karelson M; Abram K; Metsalu T; Pihlap M; Meyer N; Fölster-Holst R; Nagy N; Kemeny L; Kingo K; Vilo J; Illig T; Akdis M; Franke A; Novak N; Weidinger S; Akdis CA
    J Allergy Clin Immunol; 2012 May; 129(5):1297-306. PubMed ID: 22445417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocytes in allergic skin diseases.
    Albanesi C
    Curr Opin Allergy Clin Immunol; 2010 Oct; 10(5):452-6. PubMed ID: 20689405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of atopic dermatitis.
    Cooper KD
    Immunol Ser; 1989; 46():247-76. PubMed ID: 2484954
    [No Abstract]   [Full Text] [Related]  

  • 17. Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis.
    De Benedetto A; Slifka MK; Rafaels NM; Kuo IH; Georas SN; Boguniewicz M; Hata T; Schneider LC; Hanifin JM; Gallo RL; Johnson DC; Barnes KC; Leung DY; Beck LA
    J Allergy Clin Immunol; 2011 Jul; 128(1):242-246.e5. PubMed ID: 21489616
    [No Abstract]   [Full Text] [Related]  

  • 18. Diverse regulation of claudin-1 and claudin-4 in atopic dermatitis.
    Gruber R; Börnchen C; Rose K; Daubmann A; Volksdorf T; Wladykowski E; Vidal-Y-Sy S; Peters EM; Danso M; Bouwstra JA; Hennies HC; Moll I; Schmuth M; Brandner JM
    Am J Pathol; 2015 Oct; 185(10):2777-89. PubMed ID: 26319240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 2,4-dinitrofluorobenzene-induced atopic dermatitis by topical application of the butanol extract of Cordyceps bassiana in NC/Nga mice.
    Wu G; Li L; Sung GH; Kim TW; Byeon SE; Cho JY; Park CW; Park HJ
    J Ethnopharmacol; 2011 Mar; 134(2):504-9. PubMed ID: 21184821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of topical corticosteroid and calcineurin inhibitor on the epidermal tight junction.
    Lee SE; Choi Y; Kim SE; Noh EB; Kim SC
    Exp Dermatol; 2013 Jan; 22(1):59-61. PubMed ID: 23174045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.